Ursonic acid

• CAT Number: I004356
• CAS Number: 6246-46-4
• Molecular Formula: C30H46O3
• Molecular Weight: 454.68
• Purity: ≥95%
• Target: Metabolic Enzyme/Protease
• Solubility: DMSO
• Storage: Store at -20°C

Ursonic acid (CAT: I004356) is a pentacyclic triterpenoid with pharmacological activities including anti-inflammatory, antioxidant, and anticancer properties. It inhibits the production of inflammatory mediators, scavenges free radicals, and induces apoptosis in cancer cells. Ursonic acid has potential applications in the treatment of inflammatory diseases, metabolic disorders, and cancer. It shows promise in regulating lipid metabolism, improving insulin sensitivity, and inhibiting cell proliferation. While target information is not explicitly mentioned, its multifaceted pharmacological activities make ursonic acid a compound of interest for further research and development in various disease conditions.

Reference

[1]. Gai, L., Cai, N., Wang, L., Xu, X. & Kong, X. Ursolic acid induces apoptosis via Akt/NF-kappaB signaling suppression in T24 human bladder cancer cells. Molecular medicine reports 7, 1673-1677, doi:10.3892/mmr.2013.1364 (2013).

[2]. Manu, K. A. & Kuttan, G. Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NF-kappaB mediated activation of bcl-2 in B16F-10 melanoma cells. International immunopharmacology 8, 974-981, doi:10.1016/j.intimp.2008.02.013 (2008).

[3]. Shanmugam, M. K. et al. Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice. Journal of molecular medicine 89, 713-727, doi:10.1007/s00109-011-0746-2 (2011).